Rankings
▼
Calendar
CRDF Q4 2017 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena
CRDF
Cardiff Oncology, Inc.
$133M
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$185,000
+172.1% YoY
Gross Profit
-$198,000
-107.0% margin
Operating Income
-$4M
-2045.4% margin
Net Income
-$3M
-1389.2% margin
EPS (Diluted)
$-4.61
QoQ Revenue Growth
+50.0%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$895,221
Balance Sheet
Total Assets
$12M
Total Liabilities
$6M
Stockholders' Equity
$7M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$185,000
$68,000
+172.1%
Gross Profit
-$198,000
-$519,000
+61.8%
Operating Income
-$4M
-$10M
+61.3%
Net Income
-$3M
-$9M
+69.9%
← FY 2017
All Quarters
Q1 2018 →